Editorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease

Aliment Pharmacol Ther. 2014 Nov;40(10):1243. doi: 10.1111/apt.12958.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Crohn Disease / drug therapy*
  • Female
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use*
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Polyethylene Glycols / therapeutic use*

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin Fab Fragments
  • Immunosuppressive Agents
  • Polyethylene Glycols